Standard BioTools Inc. Cost-method Investments, Realized Gain (Loss)
Standard BioTools Inc. (LAB) reported Cost-method Investments, Realized Gain (Loss) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Income Statement › Other Income
us-gaap:CostMethodInvestmentsRealizedGainLoss · last filed 2018-03-08
- Standard BioTools Inc. cost-method investments, realized gain (loss) for the quarter ending 2015-12-31 was $2.33M.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for the quarter ending 2014-12-31 was $0.00.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for the quarter ending 2014-09-30 was $332.00K.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for the quarter ending 2014-06-30 was $0.00.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for fiscal 2017 was $0.00.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for fiscal 2015 was $2.33M, a 601.81% increase from fiscal 2014.
- Standard BioTools Inc. cost-method investments, realized gain (loss) for fiscal 2014 was $332.00K, a 81.32% decline from fiscal 2013.
| Period end | Cost-method Investments, Realized Gain (Loss) 1 month | Cost-method Investments, Realized Gain (Loss) 1 month as first filed | Cost-method Investments, Realized Gain (Loss) 3 month | Cost-method Investments, Realized Gain (Loss) 6 month | Cost-method Investments, Realized Gain (Loss) 9 month | Cost-method Investments, Realized Gain (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-08 | |||||
| 2016-12-31 | $0.00 10-K · filed 2018-03-08 | |||||
| 2015-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.33M 10-K · filed 2018-03-08 | ||||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | |||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $332.00K derived: sum of 2 quarters · filed 2017-03-03 | $332.00K derived: sum of 3 quarters · filed 2017-03-03 | $332.00K 10-K · filed 2017-03-03 | ||
| 2014-09-30 | $332.00K 10-Q · filed 2014-11-06 | $332.00K derived: sum of 2 quarters · filed 2014-11-06 | $332.00K 10-Q · filed 2015-11-09 | $332.00K derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $1.78M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $1.78M 10-Q · filed 2014-11-06 | $1.78M derived: sum of 4 quarters · filed 2015-02-26 | ||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-04 | $1.78M 10-Q · filed 2014-08-04 | $1.78M derived: sum of 3 quarters · filed 2015-02-26 | $1.78M derived: sum of 4 quarters · filed 2015-02-26 | ||
| 2013-03-31 | $1.78M 10-Q · filed 2013-11-07 | $1.80M 10-Q · filed 2013-05-09 | $1.78M 10-Q · filed 2014-05-12 | $1.78M derived: sum of 2 quarters · filed 2015-02-26 | $1.78M derived: sum of 3 quarters · filed 2015-02-26 | $1.78M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $0.00 derived: sum of 2 quarters · filed 2015-02-26 | $0.00 derived: sum of 3 quarters · filed 2015-02-26 | $0.00 10-K · filed 2015-02-26 | ||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-07 | $0.00 10-Q · filed 2013-08-07 | ||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-09 | |||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |